Cargando…

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype

BACKGROUND: Conversion to sirolimus from calcineurin inhibitor- (CNI), azathioprine- (AZA) and mycophenolate-based regimens reduces the risk of development of squamous cell carcinoma of the skin (SCC) in kidney transplant recipients (KTRs). Sirolimus conversion may also be protective by permitting b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carroll, Robert P., Hester, Joanna, Wood, Kathryn J., Harden, Paul N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572772/ https://www.ncbi.nlm.nih.gov/pubmed/23223314 http://dx.doi.org/10.1093/ndt/gfs474

Ejemplares similares

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)

Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
por: Burke, Michael Thomas, et al.
Publicado: (2017)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
por: Duhart, Benjamin T., et al.
Publicado: (2015)

Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020)

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
por: Geissler, Edward K., et al.
Publicado: (2016)

A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
por: Kasiske, Bertram L., et al.
Publicado: (2012)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Kidney transplant recipient perspectives on telehealth during the COVID‐19 pandemic
por: Huuskes, Brooke M, et al.
Publicado: (2021)

Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients
por: Sherston, S N, et al.
Publicado: (2014)

Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
por: Hedley, Adam J., et al.
Publicado: (2008)

Sirolimus-induced interstitial pneumonitis in a renal transplant recipient
por: Kanaan, Nada, et al.
Publicado: (2008)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022)

Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers
por: Cheung, Chi Yuen, et al.
Publicado: (2017)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
por: Harden, Paul N., et al.
Publicado: (2021)

Drug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
por: Masters, Joanna C., et al.
Publicado: (2014)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
por: Brook, Matthew Oliver, et al.
Publicado: (2022)

Sirolimus-Induced Rash in a Kidney Transplant Patient
por: Bruss, Zachary, et al.
Publicado: (2022)

Native Nephrectomy in Renal Transplant Recipients With Autosomal-Dominant Polycystic Kidney Disease
por: Chebib, Fouad T., et al.
Publicado: (2015)

Prognosis of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study
por: Desbois, Anne-Claire, et al.
Publicado: (2016)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
por: Joo, Dong Jin, et al.
Publicado: (2014)

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
por: Einollahi, Behzad, et al.
Publicado: (2014)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
por: Jeon, Hee Jung, et al.
Publicado: (2018)

Effect of sirolimus on carotid atherosclerosis in kidney transplant recipients: data derived from a prospective randomized controlled trial
por: Silva, Andre L, et al.
Publicado: (2018)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
por: Jordan, Stanley C., et al.
Publicado: (2021)

Cardiovascular Outcomes in Kidney Transplant Recipients With ADPKD
por: Chedid, Maroun, et al.
Publicado: (2022)

Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
por: Ali, A. A. M., et al.
Publicado: (2011)

The effect of ABCB1 polymorphism on sirolimus in renal transplant recipients: a meta-analysis
por: Shao, Shuai, et al.
Publicado: (2020)

Sirolimus in a Renal Transplant Recipient Infected With COVID-19: A Blessing in Disguise?
por: Talwar, Dhruv, et al.
Publicado: (2021)

Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study
por: El-Agroudy, A. E., et al.
Publicado: (2017)

Impact of Pregnancy on GFR Decline and Kidney Histology in Kidney Transplant Recipients
por: Kattah, Andrea G., et al.
Publicado: (2021)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Retrospective Review of ART Regimens in HIV-Positive to HIV-Positive Kidney Transplant Recipients
por: Barday, Zunaid, et al.
Publicado: (2022)

Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients
por: Tangri, Navdeep, et al.
Publicado: (2020)

Renal Function in Kidney and Liver Transplant Recipients After A 130-km Road Cycling Race
por: Mosconi, Giovanni, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vmla4ankvqlunu07jfjocppqsj